ExecRx Launches with Support from i-Cubed – Streamlining Medical Leadership for Healthcare and Research Companies

January 13, 2025

ExecRx Launches with Support from i-Cubed – Streamlining Medical Leadership for Healthcare and Research Companies

 

ExecRx finds and places fractional medical leaders and advisors in roles that support organizations engaged in healthcare and research. The new company was incubated at i-Cubed, the center for clinical research innovation at the Duke Clinical Research Institute (DCRI) 

ExecRx, so named for its prescriptive “right expertise, right dose, right time,” approach to executive and advisor placement, provides companies with fully vetted executive leaders and advisors from the nation’s top academic institutions. This allows companies to tap into the specialized expertise of best-in-class physician and scientist academicians on a fractional basis, without incurring the financial burden of full-time hires. 

This model addresses a critical need for companies in the healthcare and research sectors that often face challenges scaling their operations while maintaining the technical and clinical knowledge essential to move discoveries forward. ExecRx fills this gap by streamlining the process of identifying, placing, and supporting executives (e.g. fractional Chief Medical Officers or Chief Science Officers) and advisors (e.g. Thought Partners, Scientific Advisory Boards), empowering companies to focus on driving their mission forward. In addition to its recruitment services, ExecRx offers post-placement monitoring to ensure executives are well-integrated and continue to meet the evolving needs of the company. 

ExecRx Founder and CEO Michael Cohen-Wolkowiez said, “The right leadership, deployed in the right way, can be the difference between success and stagnation for companies in the healthcare and research sectors. We offer companies a cost-effective solution that accelerates growth, equipping them with the precise leadership needed to transform pioneering discoveries into impactful health solutions.” 

ExecRx offers an attractive opportunity for executives and advisors as well, allowing them to maintain their current academic affiliations while advancing their professional development with valuable coaching and networking opportunities. 

“We offer a practical, right-sized, and agile approach to fractional leadership and advisory needs, for both companies and executives,” said ExecRx Partner Sarah Firman. “For companies, we provide leaders and advisors with unparalleled expertise. For executives, we handle all administrative tasks, from contract negotiations to payroll, enabling them to focus on making a difference,” she said. 

“We are delighted with the launch of ExecRx. Their goals align with i-Cubed’s mission of simplifying the complex, a focus area that aims to identify and address barriers and bottlenecks to innovation, ensuring that the path from discovery to patient care is as swift and efficient as possible,” added Donna Parker, Operations Director for i-Cubed. 

To learn more, visit TheExecRx.com 

 

About i-Cubed 

i-Cubed™ is the center for clinical research innovation, powered by the unique expertise and resources of the Duke Clinical Research Institute. We support individuals, teams, and organizations in turning their ideas into tools, technologies, and processes that transform how clinical research is done — for the benefit of people everywhere. 

 Contact: 

icubedcenter@duke.edu 

i-Cubed Helps KidsHeart App Expand Care for Infants with Congenital Heart Disease

December 9, 2024

i-Cubed Helps KidsHeart App Expand Care for Infants with Congenital Heart Disease

A new app that can revolutionize pediatric care for infants born with single-ventricle heart disease will soon have a larger reach thanks to support from i-Cubed, the center for clinical research innovation at the Duke Clinical Research Institute (DCRI). 

Infants born with severe congenital heart defects such as Hypoplastic Left Heart Syndrome (HLHS), Pulmonary Atresia, or Tricuspid Atresia face one of the most vulnerable periods of their lives between their first and second heart surgeries, known as the interstage period. KidsHeart is a mobile health application that allows caregivers to track vital health data such as oxygen saturation, heart rate, and weight from home during this critical stage. Data is then automatically shared with the patient’s healthcare team, who can respond immediately if they notice any abnormal readings. 

The KidsHeart team, with strategic support from i-Cubed, worked to refine the app’s technology to increase ease of use, and conduct rigorous market feasibility assessments in preparation for commercialization. i-Cubed supports the development of sustainable, fundable startups through comprehensive resources, expert mentorship, and access to a network of resources.i-Cubed has been instrumental in helping us understand the potential business opportunities for our solution. Their support has allowed us to fine-tune KidsHeart for broader application,” said pediatric cardiologist Christoph Hornik, MD, PhD, MPH. 

KidsHeart was developed by Dr. Hornik, pediatric nurse practitioner Sarah Tallent, DNP, CPNP-AC, and Kevin Hill, MD, MHS, Chief of Pediatric Cardiology at Duke Pediatric and Congenital Heart Center, as an app-based clinical tool to power research studies. With engaged feedback from patient families, they built KidsHeart into a user-friendly home monitoring and data collection tool for caregivers. 

Managing at-home care can be a challenging and stressful time of uncertainty for patient families, leading to an average of 2.7 emergency room visits per patient in this population. The app is transforming how high-risk patients are monitored and cared for at home, allowing for early intervention and improved outcomes.  After a 2022 pilot study at Duke showed a 55% reduction in emergency room visits for KidsHeart patients, the KidsHeart team sought collaboration with i-Cubed to explore commercialization opportunities and scale the app for broader use. i-Cubed helps innovators at Duke bring their solution to life – bridging the gap between research and practical application.  

Tallent reflected on her experience working in the cardiac intensive care unit (CICU), "I was all too familiar with how devastating missing subtle signs of worsening clinical status could be, so our goal [with KidsHeart] was to catch issues early before they escalated into emergencies,” she said.  Dr. Hill reiterated, “This digital health approach has allowed us to stay better connected to our patient families.  We get more real-time feedback on their child’s progress, allowing us to keep a closer tab on some of the subtle clinical markers and intervene more quickly when we need to.” 

For families navigating the challenges of caring for an infant with congenital heart disease, KidsHeart is more than just a monitoring or research tool—it offers peace of mind, knowing that early intervention is just a tap away. Jill Brawley, mother to KidsHeart patient Maya, shared her experience: “For that crucial first year, the KidsHeart app gave us the ability to closely monitor any changes that would imply that adjustments were needed in Maya’s care. This allowed her providers to act quickly... which helped us avoid a decline in her heart health.  As a parent, you want to know every aspect of your child’s health is covered – and with the help of the KidsHeart App and our Duke providers, we had complete confidence that Maya was being thoroughly cared for.”   

Currently, 85% of Duke’s families with interstage, high-risk infants use KidsHeart, and the team plans to expand its use to other hospitals nationwide. The long-term vision for KidsHeart includes applying its technology to other high-risk pediatric populations and further augmenting the app’s research capabilities, for which the team will leverage the clinical research expertise of i-Cubed and the DCRI. “These tools can power research in patient populations that have been challenging to capture data from in an outpatient setting. Additionally, I think digital health tools like this can help develop predictive models of risk stratification, enabling clinicians to reduce mortality and ultimately improve the quality of life for pediatric patients,” Tallent said. 

Update: 

New research, published in Cardiology in the Young, shows that infants with congenital heart defects who were monitored at home with the i-Cubed innovation, KidsHeart, experienced fewer ER visits and better weight-gain outcomes. Read the full study here: duke.is/7/6tmt 

 

About i-Cubed 

i-Cubed™ is the center for clinical research innovation, powered by the unique expertise and resources of the Duke Clinical Research Institute. We support individuals, teams, and organizations in turning their ideas into tools, technologies, and processes that transform how clinical research is done — for the benefit of people everywhere. 

 Contact: 

icubedcenter@duke.edu 

DCRI’s i-Cubed Partners with BARDA to Strengthen Decentralized Clinical Trial Capabilities for Public Health Emergency Preparedness

November 13, 2024

DCRI’s i-Cubed Partners with BARDA to Strengthen Decentralized Clinical Trial Capabilities for Public Health Emergency Preparedness

i-Cubed, Duke Clinical Research Institute’s (DCRI) center for clinical research innovation, is partnering with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, for BARDA’s Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program to enhance decentralized clinical trial (DCT) capabilities to address public health emergencies (PHEs). The primary objective of this collaboration is to identify and understand the challenges and opportunities in decentralized clinical research and to develop a model for the evaluation, testing, validation, and deployment of DCT products and solutions.  

“This is a great opportunity to strengthen our nation’s decentralized trial capabilities, which, in turn, will make the entire public health infrastructure more prepared to handle future public health emergencies,” said i-Cubed Associate Director and Principal Investigator Christoph Hornik, MD, PhD. 

DCTs are clinical trials where the majority of the trial activities, such as patient recruitment data collection and study assessments, occur somewhere other than a traditional trial site. This allows participants to complete the trial at home or another convenient location. These kinds of trials are especially important during PHEs, such as the COVID-19 pandemic, when it can be challenging for participants to safely access clinical trial sites. DCTs also dramatically expand access to rural and underserved populations who are frequently left out of clinical trials. 

DCRI, with expertise through i-Cubed, was selected for this collaboration in part for its commitment to developing sustainable solutions that make clinical research more seamless and inclusive. “As part of our work at i-Cubed, we know how to develop, evaluate and implement innovative clinical research solutions. We are excited to apply our expertise to DCTs in partnership with BARDA,” i-Cubed Executive Director Micky Cohen-Wolkowiez, MD, PhD, commented. 

As part of this collaboration, i-Cubed will conduct a comprehensive assessment of the challenges and opportunities within the DCT landscape and identify and prioritize areas of greatest need for DCT innovations. i-Cubed will establish a robust, responsive, and sustainable framework to evaluate and clinically validate products and technologies intended for use in decentralized settings. Once this new infrastructure is in place, stakeholders will be able to generate and evaluate evidence to increase the use and impact of these new tools. i-Cubed will also conduct health economics and patient preference studies to further inform the impact of DCT enablers. 

Through this partnership, DCRI and BARDA aim to stimulate and accelerate expansion of decentralized clinical study capabilities to facilitate public health emergency preparedness and response and create a more resilient, adaptable, and patient-centered clinical research ecosystem, ultimately enhancing the nation’s ability to respond to public health crises.  

This project has been funded in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; Division of Research, Innovation and Ventures (“DRIVe”), under contract number: 75A50124C00056. 

About i-Cubed 

i-Cubed™ is the center for clinical research innovation, powered by the unique expertise and resources of the Duke Clinical Research Institute. i-Cubed supports individuals, teams, and organizations in turning their ideas into tools, technologies, and processes that transform how clinical research is done — for the benefit of people everywhere. 

For more details about this partnership or to explore collaboration opportunities, please contact us at icubedcenter@duke.edu.